These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 18337833)

  • 21. Epidemiological features and prognostic parameters of multiple primary melanomas in CDKN2A-mutations patients.
    De Giorgi V; Savarese I; D'Errico A; Gori A; Papi F; Colombino M; Sini MC; Grazzini M; Stanganelli I; Rossari S; Covarelli P; Massi D; Palmieri G
    Pigment Cell Melanoma Res; 2015 Nov; 28(6):747-51. PubMed ID: 26223839
    [No Abstract]   [Full Text] [Related]  

  • 22. Next-generation sequencing revealing TP53 mutation as potential genetic driver in dermal deep-seated melanoma arising in giant congenital nevus in adult patients: A unique case report and review of the literature.
    Ricci C; Ambrosi F; Grillini M; Serra M; Melotti B; Gruppioni E; Altimari A; Fiorentino M; Dika E; Lambertini M; Corti B
    J Cutan Pathol; 2020 Dec; 47(12):1164-1169. PubMed ID: 32643812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melanocortin 1 receptor (MC1R) variants in high melanoma risk patients are associated with specific dermoscopic ABCD features.
    Quint KD; van der Rhee JI; Gruis NA; Ter Huurne JA; Wolterbeek R; van der Stoep N; Bergman W; Kukutsch NA
    Acta Derm Venereol; 2012 Nov; 92(6):587-92. PubMed ID: 22965007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysplastic nevi and other risk markers for melanoma.
    Seykora J; Elder D
    Semin Oncol; 1996 Dec; 23(6):682-7. PubMed ID: 8970587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel methionine-53-valine mutation of p16 in a hereditary melanoma kindred.
    Yang G; Niendorf KB; Tsao H
    J Invest Dermatol; 2004 Sep; 123(3):574-5. PubMed ID: 15304098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acquired dysplastic melanocytic nevi and cutaneous melanoma: precursors and prevention.
    Rhodes AR
    Ann Intern Med; 1985 Apr; 102(4):546-8. PubMed ID: 3977199
    [No Abstract]   [Full Text] [Related]  

  • 27. Germline mutations predisposing to melanoma.
    Toussi A; Mans N; Welborn J; Kiuru M
    J Cutan Pathol; 2020 Jul; 47(7):606-616. PubMed ID: 32249949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CDKN2A and MC1R variants influence dermoscopic and confocal features of benign melanocytic lesions in multiple melanoma patients.
    Bassoli S; Maurichi A; Rodolfo M; Casari A; Frigerio S; Pupelli G; Farnetani F; Pelosi G; Santinami M; Pellacani G
    Exp Dermatol; 2013 Jun; 22(6):411-6. PubMed ID: 23711066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Increased risk of developing a second primary cutaneous nevus-associated melanoma in patients previously diagnosed with the disease].
    Echeverría B; Botella-Estrada R; Serra-Guillén C; Martorell A; Traves V; Requena C; Sanmartín O; Llombart B; Guillén C; Nagore E
    Actas Dermosifiliogr; 2010 Oct; 101(8):710-6. PubMed ID: 20965014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [From gene to disease; from p16 to melanoma].
    Gruis NA; Bergman W
    Ned Tijdschr Geneeskd; 2000 Oct; 144(44):2100-2. PubMed ID: 11103670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dermoscopy of melanocytic neoplasms: familial patterns.
    Grichnik JM
    Arch Dermatol; 2004 May; 140(5):642. PubMed ID: 15148119
    [No Abstract]   [Full Text] [Related]  

  • 32. Melanocytic nevi, dysplastic nevi, and malignant melanoma in children from melanoma-prone families.
    Novakovic B; Clark WH; Fears TR; Fraser MC; Tucker MA
    J Am Acad Dermatol; 1995 Oct; 33(4):631-6. PubMed ID: 7673498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysplastic nevus syndrome. Familial and sporadic precursors of cutaneous melanoma.
    Kraemer KH; Greene MH
    Dermatol Clin; 1985 Apr; 3(2):225-37. PubMed ID: 3830486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel CDKN2A mutations detected in western Swedish families with hereditary malignant melanoma.
    Erlandson A; Appelqvist F; Wennberg AM; Holm J; Enerbäck C
    J Invest Dermatol; 2007 Jun; 127(6):1465-7. PubMed ID: 17255954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melanoma-prone families: new evidence of distinctive clinical and histological features of melanomas in CDKN2A mutation carriers.
    Gironi LC; Colombo E; Pasini B; Giorgione R; Farinelli P; Zottarelli F; Esposto E; Zavattaro E; Allara E; Ogliara P; Betti M; Dianzani I; Savoia P
    Arch Dermatol Res; 2018 Dec; 310(10):769-784. PubMed ID: 30218143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular pathogenesis of malignant melanoma: a different perspective from the studies of melanocytic nevus and acral melanoma.
    Takata M; Murata H; Saida T
    Pigment Cell Melanoma Res; 2010 Feb; 23(1):64-71. PubMed ID: 19788535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families.
    Taylor NJ; Mitra N; Goldstein AM; Tucker MA; Avril MF; Azizi E; Bergman W; Bishop DT; Bressac-de Paillerets B; Bruno W; Calista D; Cannon-Albright LA; Cuellar F; Cust AE; Demenais F; Elder DE; Gerdes AM; Ghiorzo P; Grazziotin TC; Hansson J; Harland M; Hayward NK; Hocevar M; Höiom V; Ingvar C; Landi MT; Landman G; Larre-Borges A; Leachman SA; Mann GJ; Nagore E; Olsson H; Palmer JM; Perić B; Pjanova D; Pritchard A; Puig S; van der Stoep N; Wadt KAW; Whitaker L; Yang XR; Newton Bishop JA; Gruis NA; Kanetsky PA;
    J Invest Dermatol; 2017 Dec; 137(12):2606-2612. PubMed ID: 28830827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of familial melanoma.
    Bishop JN; Harland M; Randerson-Moor J; Bishop DT
    Lancet Oncol; 2007 Jan; 8(1):46-54. PubMed ID: 17196510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant and benign tumors associated with multiple primary melanomas: just the starting block for the involvement of MITF, PTEN and CDKN2A in multiple cancerogenesis?
    Pollio A; Tomasi A; Seidenari S; Pellacani G; Rodolfo M; Frigerio S; Maurichi A; Turchetti D; Bassoli S; Ruini C; Ponti G
    Pigment Cell Melanoma Res; 2013 Sep; 26(5):755-7. PubMed ID: 23802662
    [No Abstract]   [Full Text] [Related]  

  • 40. Retinoblastoma, melanoma and the atypical mole syndrome.
    Bataille V; Hiles R; Bishop JA
    Br J Dermatol; 1995 Jan; 132(1):134-8. PubMed ID: 7756125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.